**6. Conclusion**

The Lassa virus is one of several viruses that are likely to cause a future epidemic as reported by World Health Organization [4, 43, 44]. The appropriate diagnosis of Lassa fever will likely involve a combination of a clinically compatible observation along with serological and molecular diagnostic assays [5]. There is a need for urgent research and development of new diagnostic tests, vaccines, and drugs [7]. Future directions of research for diagnostics in the viral infection are improvement of assays to enhance detection of different viral strains genetically, validation of assays to depict variations in viral lineages and regions, creation of point-of-care detection and field validation, and expansion of multiplex assays content to differentiate the virus fever from other fevers with alike clinical features. Research on the virus vaccine immunogenicity in the CBA/J-ML29 mouse subjects is ongoing. Until now, no licensed vaccine for humans against the virus exists [45].

[8] Dongo AE, Kesieme EB, Iyamu CE, Okokhere PO, Akhuemokhan OC, Akpede GO. Lassa fever presenting as acute abdomen: A case series. Virology Journal. 2013;**10**:124

A Reemerging Lassa Virus: Aspects of Its Structure, Replication, Pathogenicity and Diagnosis

http://dx.doi.org/10.5772/intechopen.79072

161

[9] Hastie KM, Bale S, Kimberlin CR, Saphire EO. Hiding the evidence: Two strategies for innate immune evasion by hemorrhagic fever viruses. Current Opinion in Virology. 2012;

[11] Qi X, Lan S, Wang W, Schelde LM, Dong H, Wallat GD, Ly H, Liang Y, Dong C. Cap binding and immune evasion revealed by Lassa nucleoprotein structure. Nature. 2010;**468**:

[12] Flatz L, Rieger T, Merkler D, Bergthaler A, Regen T, Schedensack M, et al. T cell-depen-

[13] Donaldson RI. The Lassa Ward: One Man's Fight Against One of the World's Deadliest Diseases. New York, NY: St. Martin's Press, Kindle Edition; 2009. ISBN: 0-312-37700-2

[14] Branco LM, Grove JN, Boisen ML, Shaffer JG, Goba A, Fullah M, Momoh M, Grant DS, Garry RF. Emerging trends in Lassa fever: Redefining the role of immunoglobulin M

[15] National Institute of Allergy and Infectious Diseases. NIAID Emerging Infectious Diseases/Pathogens. Bethesda, MD: National Institute of Allergy and Infectious Diseases;

[16] Sogoba N, Feldmann H, Safronetz D. Lassa fever in West Africa: Evidence for an expan-

[17] Lashley FR, Jerry DD. Emerging Infectious Diseases: Trends and Issues. New York:

[18] Salazar-Bravo J, Ruedas LA, Yates TL. Mammalian reservoirs of arenaviruses. Current

[19] Buchmeier MJ, Peters CJ, de la Torre JC. Arenaviridae: The viruses and their replication. In: Knipe DM, Holey PM, editors. Fields Virology. 5th ed. Vol. 2. 2007. pp. 1792-1827

[20] Gonzalez JPJ, Bowen MD, Nichol ST, Rico-Hesse R. Genetic characterization and phylogeny of Sabiá virus, an emergent pathogen in Brazil. Virology. 1996;**221**:318-324

[21] Bowen MD, Rollin PE, Ksiazek TG, Hustad HL, Bausch DG, Demby AH, et al. Genetic diversity among Lassa virus strains. Journal of Virology. 2000;**74**(15):6992-7004

[22] O'Hearn AE, Voorhees MA, Fetterer DP, Wauquier N, Coomber MR, Bangura J, Fair JN, Gonzalez JP, Schoepp RJ. Serosurveillance of viral pathogens circulating in West Africa.

[23] Viral Hemorrhagic Fever Consortium Lassa Fever. Archived 4 April 2015 at the Wayback

ded region of endemicity. Zoonoses & Public Health. 2012;**59**(59):43-47

Topics on Microbiology and Immunology. 2002;**262**:25-63

and inflammation in diagnosing acute infection. Virology Journal. 2011;**8**:478

[10] NE Y, Walker DH. Pathogenesis of Lassa virus. Viruses. 2012;**4**(12):2031-2048

dence of Lassa fever pathogenesis. PLoS Pathogens. 2010;**6**:ee1000836

**2**(2):151-156

779-783

2016

Springer Publishers; 2002

Journal of Virology. 2016;**13**:163

Machine. Page [Accessed: April 6, 2016]

## **Author details**

Victor B. Oti

Address all correspondence to: obabavictor1@gmail.com

Department of Microbiology, Nasarawa State University, Keffi, Nigeria

## **References**


**6. Conclusion**

**Author details**

Victor B. Oti

**References**

1988;**38**:407-410

and Hygiene. 1970;**19**:695-696

The Lassa virus is one of several viruses that are likely to cause a future epidemic as reported by World Health Organization [4, 43, 44]. The appropriate diagnosis of Lassa fever will likely involve a combination of a clinically compatible observation along with serological and molecular diagnostic assays [5]. There is a need for urgent research and development of new diagnostic tests, vaccines, and drugs [7]. Future directions of research for diagnostics in the viral infection are improvement of assays to enhance detection of different viral strains genetically, validation of assays to depict variations in viral lineages and regions, creation of point-of-care detection and field validation, and expansion of multiplex assays content to differentiate the virus fever from other fevers with alike clinical features. Research on the virus vaccine immunogenicity in the CBA/J-ML29 mouse subjects is ongoing. Until now, no

licensed vaccine for humans against the virus exists [45].

160 Current Topics in Tropical Emerging Diseases and Travel Medicine

Address all correspondence to: obabavictor1@gmail.com

Department of Microbiology, Nasarawa State University, Keffi, Nigeria

Geneva, Switzerland: World Health Organization; 2016

view. Journal of Vector Borne Diseases. 2007;**44**(1):1-11

Original on 25 June 2017. 2017. Retrieved 1 February 2017

Archived 9 July 2017 at the Wayback Machine

[1] Tomori O, Fabiyi A, Sorungbe A, Smith A, McCormick JB. Viral hemorrhagic fever antibodies in Nigerian populations. American Journal of Tropical Medicine and Hygiene.

[2] Troup JM, White HA, Fom ALMD, Carey DE. An outbreak of Lassa fever on the Jos plateau, Nigeria, in January-February 1970. The American Journal of Tropical Medicine

[3] Echioya DU, Hass M, Olshlager S, Becker-Ziaja B, Chukwu COO, Coker J, et al. Lassa fever, Nigeria, 2005-2008. Emerging Infectious Diseases. 2010;**16**(6):1040-1041

[4] World Health Organization. WHO Calls for Early Diagnostic Tests for Lassa Fever.

[5] Centers for Disease Control and Prevention. 2017. Lassa Fever, Signs and Symptoms.

[6] Ogbu O, Ajuluchukwu E, Uneke CJ. Lassa fever in west African sub-region: An over-

[7] Samuel D. Lassa Fever…What You Need to Know. (PDF). Archived (PDF) from the


[24] Morin B, Coutard B, Lelke M, Ferron F, Kerber R, Jamal S, Frangeul A, Baronti C, Charrel R, de Lamballerie X, Vonrhein C, Lescar J, Bricogne G, Günther S, Canard B. The N-terminal domain of the arenavirus L protein is an RNA endonuclease essential in mRNA transcription. PLoS Pathogens. 2010;**6**:e1001038

[38] Raabe V, Koehler J. Laboratory diagnosis of Lassa fever. Journal of Clinical Microbiology.

A Reemerging Lassa Virus: Aspects of Its Structure, Replication, Pathogenicity and Diagnosis

http://dx.doi.org/10.5772/intechopen.79072

163

[39] Safronetz D, Lopez JE, Sogoba N, Traore' SF, Raffel SJ, Fischer ER, et al. Detection of

[40] Trappier SG, Conaty AL, Farrar BB, Auperin DD, McCormick JB, Fisher-Hoch SP. Evaluation of the polymerase chain reaction for diagnosis of Lassa virus infection. American

[41] Fukushi S, Tani H, Yoshikawa T, Saijo M, Morikawa S. Serological assays based on recombinant viral proteins for the diagnosis of arenavirus hemorrhagic fevers. Viruses.

[42] Bausch DG, Rollin PE, Demby AH, Coulibaly M, Kanu J, Conteh AS, et al. Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked immunosorbent assay, indirect fluorescent-antibody test, and virus isolation. Journal of Clinical Microbiology.

[43] World Health Organization. WHO Target Product Profiles for Lassa Virus Vaccine. (PDF). World Health Organization;April 2017. Retrieved 11 September 2017

[44] World Health Organization. Lassa Fever-Nigeria. Emergencies Preparedness Response.

[45] Geisbert TW, Jones S, Fritz EA, Shurtleff AC, Geisbert JB, Liebscher R, Grolla A, Stroher U, Fernando L, Daddario KM, Guttieri MC, Mothé BR, Larsen T, Hensley LE, Jahrling PB, Feldmann H. Development of a new vaccine for the prevention of Lassa fever. PLoS

[46] Günther S, Emmerich P, Laue T, Kühle O, Asper M, Jung A, Grewing T, et al. Imported Lassa fever in Germany: Molecular characterization of a new Lassa virus strain. Emerg-

[47] Asogun DA, Adomeh DI, Ehimuan J, Odia I, Hass M, Gabriel M, et al. Molecular diagnostics for Lassa fever at Irrua Specialist Teaching Hospital, Nigeria: Lessons learnt from two

[48] Olschlager S, Lelke M, Emmerich P, Panning M, Drosten C, Hass M, et al. Improved detection of Lassa virus by reverse transcription-PCR targeting the 5′ region of S

[49] Vieth S, Drosten C, Lenz O, Vincent M, Omilabu S, Hass M, et al. RT-PCR assay for detection of Lassa virus and related old world arenaviruses targeting the L gene. Transactions

[50] Briese T, Paweska JT, McMullan LK, Hutchison SK, Street C, Palacios G, Khristova ML, et al. Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-

of the Royal Society of Tropical Medicine and Hygiene. 2007;**101**:1253-1264

associated arenavirus from southern Africa. PLoS Pathogens. 2009;**5**:e1000455

years of laboratory operation. PLoS Neglected Tropical Diseases. 2012;**6**(9):e1839

RNA. Journal of Clinical Microbiology. 2010;**48**:2009-2013

Lassa virus, Mali. Emerging Infectious Diseases. 2010;**16**:1123-1126

Journal of Tropical Medicine and Hygiene. 1993;**49**:214-221

2017;**55**:1629-1637

2012;**4**:2097-2114

2000;**38**:2670-2677

Medicine. 2005;**2**(6):e183

Diseases Outbreak News (DONs); 2018

ing Infectious Diseases. 2000;**6**:466-476


[38] Raabe V, Koehler J. Laboratory diagnosis of Lassa fever. Journal of Clinical Microbiology. 2017;**55**:1629-1637

[24] Morin B, Coutard B, Lelke M, Ferron F, Kerber R, Jamal S, Frangeul A, Baronti C, Charrel R, de Lamballerie X, Vonrhein C, Lescar J, Bricogne G, Günther S, Canard B. The N-terminal domain of the arenavirus L protein is an RNA endonuclease essential in

[25] Garcin D, Kolakofsky DT. Arenavirus RNA synthesis in vitro is primer dependent and suggests an unusual model for the initiation of genome replication. Virology Journal.

[26] Cao W, Henry MD, Borrow P, Yamada H, Elder JH, Ravkov EV, Nichol ST, Compans RW, Campbell KP, Oldstone MB. Identification of -dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science. 1998;**282**(5396):2079-2081 [27] Lelke M, Brunotte L, Busch C, Günther S. An N-terminal region of Lassa virus L protein plays a critical role in transcription but not replication of the virus genome. Journal of

[28] Asper M, Sternsdorf T, Hass M, Drosten C, Rhode A, Schmitz H, Gunther S. Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a

[29] Hass M, Golnitz U, Muller S, Becker-Ziaja B, Gunther S. Replicon system for Lassa virus.

[30] Rojek JM, Moraz M, Pythoud C, Rothenberger S, Goot FG, Campbell KP, Kunz S. Binding of Lassa virus perturbs extracellular matrix-induced signal transduction via dystrogly-

[31] Centers for Disease Control and Prevention. Lassa Fever. Archived 23 September 2016 at

[32] Rojek JM, Kunz S. Cell entry by human pathogenic arenaviruses. Cellular Microbiology.

[33] Mahanty S, Hutchinson K, Agarwal S, McRae M, Rollin PE, Pulendran B. Cutting edge: Impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses.

[34] Baize S, Kaplon J, Faure C, Pannetier D, Georges-Courbot MC, Deubel V. Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate

[35] Hensley L, Smith M, Geisbert J, Fritz E, Daddario-DiCaprio K, Larsen T, Geisbert T. Pathogenesis of Lassa fever in cynomolgus macaques. Virology Journal. 2011;**8**:205 [36] Richmond JK, Baglole DJ. Lassa fever: Epidemiology, clinical features, and social conse-

[37] Drosten C, Kümmerer BM, Schmitz H, Günther S. Molecular diagnostics of viral hemor-

less pathogenic arenavirus. Journal of Virology. 2004;**78**(6):3162-3169

mRNA transcription. PLoS Pathogens. 2010;**6**:e1001038

162 Current Topics in Tropical Emerging Diseases and Travel Medicine

1992;**66**:1370-1376

Virology. 2010;**84**:1934-1944

the Wayback Machine; 2016

2008;**10**(4):828-835

Virology Journal. 2004;**78**:13793-13803

can. Cell Microbiology. 2012;**14**(7):10.1111

Journal of Immunology. 2003;**170**(6):2797-2801

quences. BMJ. 2003;**327**:1271-1275

cells. Journal of Immunology. 2004;**172**(5):2861-2869

rhagic fevers. Antiviral Research. 2003;**57**(1-2):61-87


[51] Stadhouders R, Pas SD, Anber J, Voermans J, Mes TH, Schutten M. The effect of primertemplate mismatches on the detection and quantification of nucleic acids using the 5′

[52] Trombley AR, Wachter L, Garrison J, Buckley-Beason VA, Jahrling J, Hensley LE, et al. Comprehensive panel of real-time TaqMan polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and new world hanta-

[53] Pang Z, Li A, Li J, Qu J, He C, Zhang S, Li C, Zhang Q, Liang M, Li D. Comprehensive multiplex one-step real-time TaqMan qRT-PCR assays for detection and quantification

[54] Olschlager S, Gunther S. Rapid and specific detection of Lassa virus by reverse transcription-PCR coupled with oligonucleotide array hybridization. Journal of Clinical Microbiology.

viruses. American Journal of Tropical Medicine and Hygiene. 2010;**82**:954-960

nuclease assay. The Journal of Molecular Diagnostics. 2010;**12**:109-117

of hemorrhagic fever viruses. PLoS One. 2014;**9**:e95635

164 Current Topics in Tropical Emerging Diseases and Travel Medicine

2012;**50**:2496-2499
